N-methylmitomycin A

Suppliers

Names

[ CAS No. ]:
18209-14-8

[ Name ]:
N-methylmitomycin A

[Synonym ]:
N-metil-3-clorometilpirrolidina
N-methylmitomycin A
N-metylmitomycin A
3-Chlormethyl-1-methyl-pyrrolidin
1-Methyl-3-chlormethyl-pyrrolidin
3-chloromethyl-1-methyl-pyrrolidine

Chemical & Physical Properties

[ Density]:
1.46g/cm3

[ Boiling Point ]:
568ºC at 760mmHg

[ Molecular Formula ]:
C17H21N3O6

[ Molecular Weight ]:
363.36500

[ Flash Point ]:
297.3ºC

[ Exact Mass ]:
363.14300

[ PSA ]:
112.16000

[ Vapour Pressure ]:
6.46E-13mmHg at 25°C

[ Index of Refraction ]:
1.633

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
CN0736500
CAS REGISTRY NUMBER :
18209-14-8
LAST UPDATED :
199806
DATA ITEMS CITED :
1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
5 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JMCMAR Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- Volume(issue)/page/year: 36,1461,1993

Precursor & DownStream

Precursor

DownStream

  • Porfiromycin
  • (1aS)-1,5-Dimethyl-6-methoxy-8β-(carbamoyloxymethyl)-8aα-hydroxy-1,1aα,2,8,8a,8bα-hexahydroazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione
  • 8-(Aminocarbonyloxymethyl)-1,1a,2,8b-tetrahydro-6-methoxy-1,5-dimethylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione
  • MITOMYCIN C DERIV
  • Azirino[2,3:3,4]pyrrolo[1,2-a]indole-4,7-dione, 8-[[(aminocarbonyl)oxy]methyl]-6-[[2-(ethylthio)ethyl]amino]-1,1a, 2,8,8a,8b-hexahydro-8a-methoxy-1,5-dimethyl-, [1aR-(1a.alpha., 8.beta.,8a.alpha.,8b.a

Related Compounds

  • (2S,4R)-1-((S)-2-(1-Fluorocyclopropane-1-carboxamido)-3,3-dimethylbutanoyl)-4-hydroxypyrrolidine-2-carboxylic acid
  • N-(9-((1R,3R,4R,7S)-1-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-7-hydroxy-2,5-dioxabicyclo[2.2.1]heptan-3-yl)-9H-purin-6-yl)benzamide
  • (2S,4R)-4-Hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide hydrochloride
  • N,a-Dimethyl-N-2-propynyl-(3-pyridinyl)ethanamine
  • 4-Hydroxy-2,6-dimesityl-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide
  • (R)-4-((3-Chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)pyrimidine-5-carboxylic acid
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • 1-(4-Bromo-1-methyl-1h-pyrazol-3-yl)-2-pyrrolidinone
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine
  • 4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide